Medicare Enrolled
Dr. Noune Pashinian, MD
Rheumatology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pashinian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pashinian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pashinian
Dr. Noune Pashinian is a rheumatology specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pashinian performed 19,724 Medicare services across 5,860 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pashinian received a total of $45,142 from 51 pharmaceutical and/or device companies across 1024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pashinian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in CA
$45,142 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,724
Medicare services
Top 18% in CA for rheumatology
5,860
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,038 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Joint lubricant injection (Synvisc) | 3,936 | $7 | $25 |
| Denosumab injection (Prolia/Xgeva) | 3,060 | $19 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,010 | $75 | $175 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,900 | $1 | $10 |
| Joint lubricant injection (Durolane) An injection of hyaluronan or its derivative, specifically Durolane, administered directly into a joint space. |
1,320 | $6 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
894 | $8 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
839 | $12 | $40 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
767 | $93 | $265 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
624 | $44 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
452 | $103 | $250 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
445 | $101 | $249 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
399 | $138 | $350 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
389 | $36 | $175 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
345 | $4 | $10 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
212 | $60 | $172 |
| Methotrexate sodium, 5 mg | 195 | $0 | $3 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
155 | $51 | $275 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $49 | $125 |
| Tendon injection at attachment site A procedure involving the injection of medication into a tendon where it attaches to bone or muscle. |
115 | $49 | $110 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
76 | $67 | $150 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
75 | $86 | $223 |
| Hyaluronan intra-articular injection An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning. |
56 | $559 | $1,200 |
| Injection, methylprednisolone acetate, 40 mg | 54 | $6 | $20 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
53 | $47 | $131 |
| Injection of carpal tunnel | 51 | $76 | $174 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
47 | $0 | $25 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
45 | $48 | $133 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
25 | $46 | $175 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
20 | $46 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $141 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $97 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$45,142
Total received (2018-2024)
Avg $6,449/year across 7 years
Top 11% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,024
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,509 (54.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,633 (45.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,943
2023
$2,707
2022
$3,836
2021
$2,460
2020
$6,390
2019
$13,914
2018
$11,892
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,364
Janssen Biotech, Inc.
$400
Amgen Inc.
$347
Novartis Pharmaceuticals Corporation
$254
GlaxoSmithKline, LLC.
$243
Lilly USA, LLC
$226
UCB, Inc.
$182
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
PFIZER INC.
$141
Fresenius Kabi USA, LLC
$122
Alexion Pharmaceuticals, Inc.
$72
SCILEX PHARMACEUTICALS INC.
$72
AstraZeneca Pharmaceuticals LP
$63
Boston Scientific Corporation
$55
Genentech USA, Inc.
$48
Alvogen Inc
$41
SHORLA ONCOLOGY INC.
$29
Radius Health, Inc.
$27
SOBI, INC
$25
DePuy Synthes Sales Inc.
$22
Kiniksa Pharmaceuticals International, plc
$22
Azurity Pharmaceuticals, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
Top 3 companies account for 53.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$20,387
Amgen Inc.
$4,503
AbbVie Inc.
$4,348
ABBVIE INC.
$2,861
Novartis Pharmaceuticals Corporation
$1,443
Lilly USA, LLC
$1,435
Radius Health, Inc.
$1,334
Janssen Biotech, Inc.
$1,251
GlaxoSmithKline, LLC.
$1,225
Celgene Corporation
$1,212
PFIZER INC.
$1,051
Genentech USA, Inc.
$513
Boehringer Ingelheim Pharmaceuticals, Inc.
$488
UCB, Inc.
$360
Aurinia Pharma U.S., Inc.
$330
Horizon Therapeutics plc
$225
E.R. Squibb & Sons, L.L.C.
$224
AstraZeneca Pharmaceuticals LP
$202
GENZYME CORPORATION
$176
Fresenius Kabi USA, LLC
$175
Arbor Pharmaceuticals, Inc.
$104
Alexion Pharmaceuticals, Inc.
$97
Mallinckrodt Hospital Products Inc.
$89
DePuy Synthes Sales Inc.
$73
SCILEX PHARMACEUTICALS INC.
$72
Nestle HealthCare Nutrition Inc.
$71
Celltrion USA Inc.
$68
Sobi, Inc
$62
Hikma Pharmaceuticals USA
$60
Actelion Pharmaceuticals US, Inc.
$59
ARBOR PHARMACEUTICALS, INC.
$58
Azurity Pharmaceuticals, Inc.
$58
Boston Scientific Corporation
$55
SOBI, INC
$45
Alvogen Inc
$41
MEDAC PHARMA, INC.
$40
Amarin Pharma Inc.
$40
Oxford Immunotec USA Inc
$39
Gilead Sciences, Inc.
$37
Horizon Pharma plc
$31
SHORLA ONCOLOGY INC.
$29
Kiniksa Pharmaceuticals International, plc
$22
Ultragenyx Pharmaceutical Inc.
$22
Eyevance Pharmaceuticals LLC
$21
Merck Sharp & Dohme Corporation
$19
Teva Pharmaceuticals USA, Inc.
$17
Phadia US Inc.
$16
West-Ward Pharmaceuticals
$14
Medicure Pharma Inc.
$13
United Therapeutics Corporation
$13
Zyla Life Sciences
$13
Top 3 companies account for 64.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aimovig · Arcalyst · BENLYSTA · BEXSERO · Bimzelx · COSENTYX · CREON · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Edarbi · Enbrel · FORTEO · HORIZANT · HUMIRA · Horizant · Humira · IDACIO · ILARIS · ImmunoCAP · JYLAMVO · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OFEV · OPSUMIT · ORENCIA · ORENITRAM · ORTHOVISC · Otezla · PEDIARIX · PENNSAID · PREVNAR 20 · Prolia · RAYOS · REMICADE · RINVOQ · ROTATEQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · TALTZ · TERIPARATIDE · TREMFYA · TSPOT TB TEST · Tobradex ST · Truxima · Tymlos · Vascepa · WaveWriter Alpha Prime 16 · XELJANZ · YUFLYMA · ZENPEP · ZTLido · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Rheumatologists within 10 mi
209
Per 100K population
2.1
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pashinian is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with speaking/promotional industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pashinian experienced with joint lubricant injection (synvisc)?
Based on Medicare claims data, Dr. Pashinian performed 3,936 joint lubricant injection (synvisc) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pashinian receive payments from pharmaceutical companies?
Yes. Dr. Pashinian received a total of $45,142 from 51 companies across 1,024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pashinian's costs compare to other rheumatologists in Glendale?
Dr. Pashinian's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pashinian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Glendale
Browse rheumatologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology